PDL BIOPHARMA INC

CUSIP: 69329Y104 Class: COM

MACKENZIE FINANCIAL CORP's Holding History (CIK: 0000919859)

Note: Option positions (PUT/CALL) are excluded.

Q1 2020
Shares 24,950 Value ($000) $70 Avg Close — Range —
Q3 2019
Shares 36,000 Value ($000) $78 Avg Close — Range —
Q2 2019
Shares 36,000 Value ($000) $113 Avg Close — Range —
Q1 2019
Shares 40,050 Value ($000) $149 Avg Close — Range —
Q4 2018
Shares 40,050 Value ($000) $116 Avg Close — Range —
Q3 2018
Shares 40,050 Value ($000) $105 Avg Close — Range —
Q2 2018
Shares 17,400 Value ($000) $41 Avg Close — Range —
Q1 2018
Shares 4,965,762 Value ($000) $14,599 Avg Close — Range —
Q4 2017
Shares 4,853,362 Value ($000) $13,298 Avg Close — Range —
Q3 2017
Shares 5,074,015 Value ($000) $17,201 Avg Close — Range —
Q2 2017
Shares 3,650,544 Value ($000) $9,017 Avg Close — Range —
Q1 2017
Shares 4,818,609 Value ($000) $10,938 Avg Close — Range —
Q4 2016
Shares 4,687,825 Value ($000) $9,938 Avg Close — Range —
Q3 2016
Shares 5,800,811 Value ($000) $19,433 Avg Close — Range —
Q2 2016
Shares 5,061,825 Value ($000) $15,894 Avg Close — Range —
Q1 2016
Shares 3,450,178 Value ($000) $11,489 Avg Close — Range —
Q4 2015
Shares 2,859,600 Value ($000) $10,123 Avg Close — Range —